Mishal Mendiratta-Lala
Overview
Explore the profile of Mishal Mendiratta-Lala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aslam A, Chernyak V, Tang A, Miller F, Bashir M, Do R, et al.
Radiology
. 2025 Feb;
314(2):e259002.
PMID: 39998379
No abstract available.
2.
Taddei T, Brown D, Yarchoan M, Mendiratta-Lala M, Llovet J
Hepatology
. 2025 Feb;
PMID: 39992051
No abstract available.
3.
Wehrle C, Burns K, Ong E, Couillard A, Parikh N, Caoili E, et al.
J Gastrointest Surg
. 2025 Feb;
29(4):102000.
PMID: 39978577
Background: Histotripsy is a novel, noninvasive, nonionizing, and nonthermal approach that uses focused ultrasound waves to treat liver tumors. This technology received a de novo Food and Drug Administration grant...
4.
Seif El Dahan K, Yokoo T, Mendiratta-Lala M, Fetzer D, Davenport M, Daher D, et al.
Abdom Radiol (NY)
. 2024 Nov;
PMID: 39542949
Purpose: MRI is a potential alternative to ultrasound for hepatocellular carcinoma (HCC) detection. We evaluated the impact of ultrasound and dynamic abbreviated MRI (AMRI) exam quality on early-stage HCC detection....
5.
Aslam A, Chernyak V, Miller F, Bashir M, Do R, Sirlin C, et al.
Radiology
. 2024 Nov;
313(2):e232408.
PMID: 39530896
With the rising incidence of hepatocellular carcinoma, there has been increasing use of local-regional therapy (LRT) to downstage or bridge to transplant, for definitive treatment, and for palliation. The CT/MRI...
6.
Kamal O, Haghshomar M, Yang J, Lalani T, Bijan B, Yaghmai V, et al.
Abdom Radiol (NY)
. 2024 Oct;
PMID: 39433603
Hepatocellular carcinoma (HCC), the most common primary liver cancer, is a significant global health burden. Accurate imaging is crucial for diagnosis and treatment response assessment, often eliminating the need for...
7.
Harmath C, Fung A, Aslam A, Kamath A, Lall C, Surabhi V, et al.
Abdom Radiol (NY)
. 2024 Oct;
PMID: 39424663
Locoregional treatments (LRT) continue to advance for hepatocellular carcinoma (HCC). Selective internal radiation therapy (SIRT) or transarterial radioembolization (TARE) with radioactive Yttrium (Y90) microspheres is currently widely accepted, and external...
8.
Mendiratta-Lala M, Wiggermann P, Pech M, Serres-Creixams X, White S, Davis C, et al.
Radiology
. 2024 Sep;
312(3):e233051.
PMID: 39225612
Background Histotripsy is a nonthermal, nonionizing, noninvasive, focused US technique that relies on cavitation for mechanical tissue breakdown at the focal point. Preclinical data have shown its safety and technical...
9.
Parikh N, Jones P, Salgia R, Bhan I, Grinspan L, Jou J, et al.
Clin Gastroenterol Hepatol
. 2024 Aug;
23(2):281-290.e4.
PMID: 39089513
Background & Aims: Noninvasive variceal risk stratification systems have not been validated in patients with hepatocellular carcinoma (HCC), which presents logistical barriers for patients in the setting of systemic HCC...
10.
Frenette C, Mendiratta-Lala M, Salgia R, Wong R, Sauer B, Pillai A
Am J Gastroenterol
. 2024 Jul;
119(7):1235-1271.
PMID: 38958301
Focal liver lesions (FLLs) have become an increasingly common finding on abdominal imaging, especially asymptomatic and incidental liver lesions. Gastroenterologists and hepatologists often see these patients in consultation and make...